MSD's COVID-19 Pill Molnupiravir Gains First Approval In UK
To Be Marketed As Lagevrio
The UK becomes the first country to grant a marketing authorization for the oral treatment which could help cut hospitalizations and deaths by half.
The UK becomes the first country to grant a marketing authorization for the oral treatment which could help cut hospitalizations and deaths by half.